File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: FOXO1 Couples Reactive Oxygen Species in Diabetic Atherosclerosis

TitleFOXO1 Couples Reactive Oxygen Species in Diabetic Atherosclerosis
Authors
Issue Date2018
PublisherFederation of American Societies for Experimental Biology. The Journal's web site is located at http://www.fasebj.org/
Citation
Experimental Biology 2018 Meeting, San Diego, CA, 21-25 April 2018 in The FASEB Journal, 2018, v. 32, p. abstract Number:569.8 How to Cite?
AbstractDiabetic atherosclerosis, distinct from other type of atherosclerosis, is progressing rapidly which is the leading cause of morbidity and mortality in the entire world, and no effective therapy has been established so far. Thus, an intensive search for new therapeutic targets in diabetic atherosclerosis is needed. A growing evidences are that post translational modifications of FOXO1 triggered by hyperglycemia-induced reactive oxygen species (ROS) which is most likely primarily responsible for hyperglycemia, plays an important role in diabetic atherosclerosis progression.Here, we investigated whether the inhibition of FOXO1 alters diabetes-associated atherosclerosis. Our study found that pharmacologic inhibition of FOXO1 markedly suppressed the vascular remodeling in DM though attenuating overproduction of ROS, increasing antioxidant function in conjunction with enhancing antioxidant activity, and reducing ROS induced inflammation and fibrosis in carotid artery. Moreover, in T1DM rats, FOXO1 translocate into the tunica intima of carotid artery after treatment of pharmacologic inhibition of FOXO1, which coupled with the activation of PI3K/Akt/mTOR pathway. In addition, inactivation of PI3K/Akt/mTOR pathway in diabetic carotid artery was restored by pharmacologic inhibition of FOXO1 and the anti-ROS effect of pharmacologic inhibition of FOXO1 was partially inhibited by a PI3K inhibitor (LY294002) and also enhanced p-Akt/Akt protein ratio. Therefore, we hypothesis that pharmacologic inhibition of FOXO1 attenuate hyperglycemia-induced ROS generation associated with activation of PI3K/Akt/mTOR pathway signaling, which may be a promising target for treating diabetic atherosclerosis and subsequent cardiovascular diseases.
DescriptionAbstract
Persistent Identifierhttp://hdl.handle.net/10722/263236
ISSN
2019 Impact Factor: 4.966
2015 SCImago Journal Rankings: 2.775

 

DC FieldValueLanguage
dc.contributor.authorLiu, J-
dc.contributor.authorYAN, D-
dc.contributor.authorXIE, X-
dc.contributor.authorXia, Z-
dc.date.accessioned2018-10-22T07:35:41Z-
dc.date.available2018-10-22T07:35:41Z-
dc.date.issued2018-
dc.identifier.citationExperimental Biology 2018 Meeting, San Diego, CA, 21-25 April 2018 in The FASEB Journal, 2018, v. 32, p. abstract Number:569.8-
dc.identifier.issn0892-6638-
dc.identifier.urihttp://hdl.handle.net/10722/263236-
dc.descriptionAbstract-
dc.description.abstractDiabetic atherosclerosis, distinct from other type of atherosclerosis, is progressing rapidly which is the leading cause of morbidity and mortality in the entire world, and no effective therapy has been established so far. Thus, an intensive search for new therapeutic targets in diabetic atherosclerosis is needed. A growing evidences are that post translational modifications of FOXO1 triggered by hyperglycemia-induced reactive oxygen species (ROS) which is most likely primarily responsible for hyperglycemia, plays an important role in diabetic atherosclerosis progression.Here, we investigated whether the inhibition of FOXO1 alters diabetes-associated atherosclerosis. Our study found that pharmacologic inhibition of FOXO1 markedly suppressed the vascular remodeling in DM though attenuating overproduction of ROS, increasing antioxidant function in conjunction with enhancing antioxidant activity, and reducing ROS induced inflammation and fibrosis in carotid artery. Moreover, in T1DM rats, FOXO1 translocate into the tunica intima of carotid artery after treatment of pharmacologic inhibition of FOXO1, which coupled with the activation of PI3K/Akt/mTOR pathway. In addition, inactivation of PI3K/Akt/mTOR pathway in diabetic carotid artery was restored by pharmacologic inhibition of FOXO1 and the anti-ROS effect of pharmacologic inhibition of FOXO1 was partially inhibited by a PI3K inhibitor (LY294002) and also enhanced p-Akt/Akt protein ratio. Therefore, we hypothesis that pharmacologic inhibition of FOXO1 attenuate hyperglycemia-induced ROS generation associated with activation of PI3K/Akt/mTOR pathway signaling, which may be a promising target for treating diabetic atherosclerosis and subsequent cardiovascular diseases.-
dc.languageeng-
dc.publisherFederation of American Societies for Experimental Biology. The Journal's web site is located at http://www.fasebj.org/-
dc.relation.ispartofThe FASEB Journal-
dc.titleFOXO1 Couples Reactive Oxygen Species in Diabetic Atherosclerosis-
dc.typeConference_Paper-
dc.identifier.emailLiu, J: jingjinl@HKUCC-COM.hku.hk-
dc.identifier.emailXia, Z: zyxia@hkucc.hku.hk-
dc.identifier.authorityXia, Z=rp00532-
dc.identifier.hkuros295393-
dc.identifier.volume32-
dc.identifier.spageabstract Number:569.8-
dc.identifier.epageabstract Number:569.8-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats